Article

Is CNS Involvement in AML Patients predictable? Analyzing Risk Factors, Clinical Outcomes, and the Impact of Next-Generation Sequencing

2024-10-08

Abstract excerpt

CNS infiltration (CNS+) leads to serious complications in AML. Cytogenetic and Molecular profile is essential in risk stratification, treatment decisions and envisage prognosis. We utilize the NGS data and cytogenetics as a screening tool, for determining the incidences and specific CNS+ risks, in patients eligible for intrathecal chemotherapy. 52 mutations database per NGS was used for the analysis. 435 newly dia...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 317ad441-541d-5802-a24b-6362507667e3
DOI: 10.20944/preprints202410.0568.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Is CNS Involvement in AML Patients predictable? Analyzing Risk Factors, Clinical Outcomes, and the Impact of Next-Generation SequencingDOI 10.20944/preprints202410.0568.v1Read

Clinical Characteristics, Molecular Analysis and Survival Outcomes of Patients With Extramedullary Acute Myeloid Leukemia: A Retrospective Single-Center Study.Semantic proximity Read

Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples.Semantic proximity Read

Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics ApproachSemantic proximity Read

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.Semantic proximity Read

[Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].Semantic proximity Read

[AML in Adults - An Update on Diagnosis, Risk Classification and Therapy].Semantic proximity Read

[Analysis of risk factors for early death in NPM1-mutated acute myeloid leukemia patients].Semantic proximity Read

Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasmsSemantic proximity Read

An abnormality in the cerebrospinal fluid before transplantation is predictive of poor outcomes after allotransplantation in AML patientsSemantic proximity Read

Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia.Semantic proximity Read

Genetic mutations and immune microenvironment: unveiling the connection to AML prognosis.Semantic proximity Read

Advancing Leukemia Diagnostics: Role of Next Generation Sequencing (NGS) in Acute Myeloid LeukemiaSemantic proximity Read